Preclinical prediction of Alzheimer's disease using SPECT
Abstract
BACKGROUND: Regional cerebral perfusion measured by single photon emission computed tomography (SPECT) was examined as a preclinical predictor of the development of Alzheimer's disease (AD). METHODS: Singular value decomposition was used to produce 20 SPECT factors (known as vectors) (n=152). Vector scores were then computed for four groups (n=136), differing in cognitive status: Group 1--normal controls at both baseline and follow-up; Group 2--subjects with "questionable" AD at both baseline and follow-up; Group 3--subjects with questionable AD at baseline who converted to AD on follow-up (Converters); Group 4--subjects with AD at baseline. All SPECT data in the analyses were gathered at baseline. RESULTS: The four groups could be distinguished on the basis of their baseline SPECT data (p < or = 0.00005; hit rate=83%). Regional decreases in perfusion were most prominent among Converters in the hippocampal-amygdaloid complex, the posterior cingulate, the anterior thalamus, and the anterior cingulate. Inclusion of apolipoprotein E status did not significantly improve the discrimination. CONCLUSIONS: SPECT data gathered and analyzed in this manner may be useful as one aspect of the preclinical prediction of AD. Three of the four brain regions important for discriminating Converters from normal controls involve a distributed brain network pertaining to memory, suggesting that this network may be selectively affected in the earliest stages of AD.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Reduced size or glucose metabolism (METglu) in the EC, Hip, temporal neocortex, and posterior cingulate gyrus have been shown to predict the MCI conversion to Alzheimer's disease.
“Reduced size or glucose metabolism (METglu) in the EC (10), Hip (11–16), temporal neocortex (17–20), and posterior cingulate gyrus (16) have been shown to predict the MCI conversion to AD.”
The SPECT study by Johnson et al. demonstrated that reduced perfusion of the Hip and posterior cingulate gyrus predicted AD.
“The recent SPECT study by Johnson et al. (16) demonstrated that reduced perfusion of the Hip and posterior cingulate gyrus predicted AD.”
Cited by
Sorted by citations
Fischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00569-x · Cited by 8,610 · see citing works
Self-citationFunctional connectivity in the resting brain: a network analysis of the default mode hypothesis
Greicius, M. D., Krasnow, B., Reiss, A. L., & Menon, V. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0135058100 · Cited by 6,358 · see citing works
Gauthier, S. G., Reisberg, ., Zaudig, M., Petersen, R. C., Ritchie, K. A., Broich, K., Belleville, S., Brodaty, H., Bennett, D. A., Chertkow, H. M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 3,920 · see citing works
Greicius, M. D., Srivastava, G., Reiss, A. L., & Menon, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308627101 · Cited by 3,684 · see citing works
The role of the posterior cingulate cortex in cognition and disease
Leech, R., & Sharp, D. J. (2014) · Brain · doi:10.1093/brain/awt162 · Cited by 2,247 · see citing works
“These metabolic changes might reflect damage in remote but connected regions (Johnson et al., 1998).”
BackgroundDynamics of Gray Matter Loss in Alzheimer's Disease
Thompson, P. M., Hayashi, K. M., de Zubicaray, G., Janke, A. L., Rose, S. E., Semple, J., Herman, D., Hong, M. S., Dittmer, S. S., Doddrell, D. M., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00994.2003 · Cited by 1,132 · see citing works
“This is consistent with previous reports of the left hemisphere being more severely affected in AD, both metabolically and structurally (Friedland and Luxenberg, 1988; Loewenstein et al., 1989; Johnson et al., 1998; Janke et al., 2001; Thompson et al., 2001b).”
ResultSperling, R. A., LaViolette, P. S., O'Keefe, K., O'Brien, J., Rentz, D. M., Pihlajamaki, M., Marshall, G., Hyman, B. T., Selkoe, D. J., Hedden, T., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.07.003 · Cited by 1,027 · see citing works
“The PPC region typically demonstrates hypometabolism on FDG-PET and decreased perfusion in SPECT and arterial spin labeling (ASL) MRI in AD (Johnson et al., 1998, 2005; Minoshima et al., 1997).”
Self-citationIncreased hippocampal activation in mild cognitive impairment compared to normal aging and AD
Dickerson, B. C., Salat, D. H., Greve, D. N., Chua, E. F., Rand-Giovannetti, E., Rentz, D. M., Bertram, L., Mullin, K., Tanzi, R. E., Blacker, D., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000171450.97464.49 · Cited by 910 · see citing works
Self-citationPetersen, R. C. (2016) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000313 · Cited by 925 · see citing works
Alzheimer Disease as a Vascular Disorder
de la Torre, J. C. (2002) · Stroke · doi:10.1161/01.str.0000014421.15948.67 · Cited by 844 · see citing works
Classification criteria for mild cognitive impairment
Ritchie, K. A., Artéro, S., & Touchon, J. (2001) · Neurology · doi:10.1212/wnl.56.1.37 · Cited by 831 · see citing works
“Previous clinical studies of MCI have suggested that subjects with MCI may have smaller medial temporal lobe volumes, 8-11 and that risk factors for progression from MCI to AD are higher age, the presence of the APOE e 4 allele, fine motor deficit, and lower premor-bid IQ.”
BackgroundThe Preclinical Phase of Alzheimer Disease: A 22-Year Prospective Study of the Framingham Cohort
Elias, M. F., Beiser, A., Wolf, P. A., Au, R., White, R. F., & D'Agostino, R. B. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.808 · Cited by 716 · see citing works
Incidence and outcome of mild cognitive impairment in a population-based prospective cohort
Larrieu, S., Letenneur, L., Orgogozo, J., Fabrigoule, C., Amieva, H., Carret, N. L., Barberger‐Gateau, P., & Dartigues, J. (2002) · Neurology · doi:10.1212/01.wnl.0000034176.07159.f8 · Cited by 663 · see citing works
Pihlajam�ki, M., Tanila, H., H�nninen, T., Könönen, M., Laakso, M. P., Partanen, K. P. L., Soininen, H. S., & Aronen, H. J. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4 · Cited by 210 · see citing works
Self-citationde Leon, M. J., Convit, A., Wolf, O. T., Tarshish, C. Y., DeSanti, S., Rusinek, H., Tsui, W., Kandil, E., Scherer, A. J., Roche, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191044198 · Cited by 629 · see citing works
Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease
Karas, G. B., Scheltens, P., Rombouts, S. A. R. B., Visser, P. J., van Schijndel, R. A., Fox, N. C., & Barkhof, F. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.07.006 · Cited by 613 · see citing works
“, 2001, 2003), SPECT and PET studies (Duara et al., 1986; Johnson et al., 1998; Loewenstein et al., 1989), which support left greater than right hemispheric involvement in AD.”
Chételat, G., Desgranges, B., Sayette, V. D. L., Viader, F., Eustache, F., & Baron, J. (2003) · Neurology · doi:10.1212/01.wnl.0000055847.17752.e6 · Cited by 604 · see citing works
Johnson, N. A., Jahng, G., Weiner, M. W., Miller, B. L., Chui, H. C., Jagust, W. J., Gorno‐Tempini, M. L., & Schuff, N. W. (2005) · Radiology · doi:10.1148/radiol.2343040197 · Cited by 580 · see citing works
Medial temporal lobe function and structure in mild cognitive impairment
Dickerson, B. C., Salat, D. H., Bates, J. F., Atiya, M., Killiany, R., Greve, D. N., Dale, A. M., Stern, C. E., Blacker, D., Albert, M., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20163 · Cited by 561 · see citing works
Self-citationThe Alzheimer's disease Beta-secretase enzyme, BACE1
Cole, S. L., & Vassar, R. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-22 · Cited by 550 · see citing works
“Indeed, CBH is a pre-clinical condition of mild cognitive impairment (MCI), a condition thought to precede AD, and is an accurate indicator for predicting the development of AD [194-198].”
Modrego, P. J., & Ferrández, J. (2004) · Archives of Neurology · doi:10.1001/archneur.61.8.1290 · Cited by 539 · see citing works
“( 3 ) Logical memory: immediate and delayed recall of a brief story.Maximumscore:24pointsforeach.(4)Digitspan(number of digits recalled forward).”
BackgroundPreclinical prediction of AD using neuropsychological tests
Albert, M., Moss, M. B., Tanzi, R. E., & JONES, K. (2001) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617701755105 · Cited by 517 · see citing works
Self-citationMorris, J. C., & Price, J. L. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:101 · Cited by 513 · see citing works
Retinal Abnormalities in Early Alzheimer’s Disease
Berisha, F., Feke, G. T., Trempe, C. L., McMeel, J. W., & Schepens, C. L. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-1029 · Cited by 505 · see citing works
“Cerebral blood flow is known to be impaired in patients with MCI, the preclinical stage of AD.(31,32) Whether retinal hemodynamic abnormalities or retinal neuronal loss is also present in MCI must be determined.”
BackgroundPerry, R. J., Watson, P., & Hodges, J. R. (2000) · Neuropsychologia · doi:10.1016/s0028-3932(99)00079-2 · Cited by 491 · see citing works
A Generative Model for Image Segmentation Based on Label Fusion
Sabuncu, M. R., Yeo, B. T. T., Leemput, K. V., Fischl, B. R., & Golland, P. (2010) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2010.2050897 · Cited by 471 · see citing works
Reiman, E. M., Caselli, R. J., Chen, K., Alexander, G. E., Bandy, D., & Frost, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061509598 · Cited by 467 · see citing works
Advances in the early detection of Alzheimer's disease
Nestor, P. J., Scheltens, P., & Hodges, J. R. (2004) · Nature Medicine · doi:10.1038/nrn1433 · Cited by 465 · see citing works
“For instance, SPECT showed that individuals with MCI who subsequently converted to AD had hypoperfusion in the posterior cingulate corte”
BackgroundRegional metabolic patterns in mild cognitive impairment and Alzheimer’s disease
Kantarci, K., Jack, C. R., Xu, Y., Campeau, N. G., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Kokmen, E., Tangalos, E. G., et al. (2000) · Neurology · doi:10.1212/wnl.55.2.210 · Cited by 460 · see citing works
Cortical Change in Alzheimer's Disease Detected with a Disease-specific Population-based Brain Atlas
Thompson, P. M., Mega, M. S., Woods, R. P., Zoumalan, C. I., Lindshield, C., Blanton, R. E., Moussai, J., Holmes, C. J., Cummings, J. L., & Toga, A. W. (2001) · Cerebral Cortex · doi:10.1093/cercor/11.1.1 · Cited by 438 · see citing works
“Greatest gray matter loss in the temporoparietal cortex may underlie the prominent temporal-parietal hypometabolism that is consistently found at this stage of AD, often asymmetrically (Friedland and Luxenberg, 1988; Johnson et al., 1998).”
BackgroundHan, Y., Wang, J., Zhao, Z., Min, B., Lu, J., Li, K., Yong He, A., & Jia, J. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.11.059 · Cited by 442 · see citing works
“…inmanybrain regions, including theposterior cingulate cortex (PCC), precuneus (PCu), and temporal and parietal cortical regions (Anchisi et al., 2005; Chetelat et al., 2003; Hirao et al., 2005; Jagust, 2006; Johnson et al., 1998; Matsuda, 2007; Minoshima et al., 1997; Nestor et al., 2003).”
BackgroundNeuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future
Petrella, J. R., Coleman, R. E., & Doraiswamy, P. M. (2003) · Radiology · doi:10.1148/radiol.2262011600 · Cited by 427 · see citing works
“Authors of another study (81), using a quantitative singular-value decomposition analysis of SPECT images in patients with MCI, demonstrated regional decreases in uptake in the medial temporal lobe and cingulate regions that were most prominent among patients with MCI who subsequently converted to AD over the 1- to 2-…”
ResultSOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein
Iadecola, C., Zhang, F., Niwa, K., Eckman, C., Turner, S. K., Fischer, E., Younkin, S., Borchelt, D. R., Hsiao, K. K., & Carlson, G. A. (1999) · Nature Neuroscience · doi:10.1038/5715 · Cited by 399 · see citing works
“Although the CBF alterations in Alzheimer's dementia could be secondary to neuronal degeneration or to morphological alterations in cerebral blood vessels, these factors are less likely to be involved in the cerebrovascular changes occurring early in the disease when pathological changes have not yet occurre”
BackgroundThe inter-relationship between delirium and dementia: the importance of delirium prevention
Fong, T. G., & Inouye, S. K. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00698-7 · Cited by 404 · see citing works
Mild cognitive impairment: conceptual basis and current nosological status
Ritchie, K. A., & Touchon, J. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06155-3 · Cited by 386 · see citing works
Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry
Frisoni, G. B. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.6.657 · Cited by 386 · see citing works
Thal, D. R., Ghebremedhin, E., Orantes, M., & Wiestler, O. D. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.12.1287 · Cited by 384 · see citing works
Predicting Conversion to Alzheimer Disease Using Standardized Clinical Information
Daly, E. J., Zaitchik, D., Copeland, M., Schmahmann, J. D., Gunther, J. M., & Albert, M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.5.675 · Cited by 358 · see citing works
“Once the interview was completed and rated, the subjects in the study were administered other study procedures, which included a neuropsychological battery, a magnetic resonance imaging scan, and a single photon emission computed tomographic scan.(13) The ratings of the interview were completed with the interviewers b…”
MethodSelf-citationMCI conversion to dementia and the APOE genotype
Mosconi, L., Perani, D., Sorbi, S., Herholz, K., Nacmias, B., Holthoff‐Detto, V., Salmon, É., Baron, J., Cristofaro, M. T. D., Padovani, A., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000147469.18313.3b · Cited by 344 · see citing works
Resting Brain Connectivity: Changes during the Progress of Alzheimer Disease
Zhang, H.-Y., Wang, S.-J., Liu, B., Ma, Z.-L., Yang, M., Zhang, Z.-J., & Teng, G.-J. (2010) · Radiology · doi:10.1148/radiol.10091701 · Cited by 320 · see citing works
Evidence that Alzheimer’s disease is a microvascular disorder: the role of constitutive nitric oxide
de la Torre, J. C., & Stefano, G. B. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00043-6 · Cited by 307 · see citing works
Fellgiebel, A., Wille, P., Müller, M. J., Winterer, G., Scheurich, A., Vucurevic, G., Schmidt, L. G., & Stoeter, P. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000077817 · Cited by 298 · see citing works
Mild cognitive impairment and Alzheimer disease: regional diffusivity of water
Kantarci, K., Jack, C. R., Xu, Y. C., Campeau, N. G., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Kokmen, E., Tangalos, E. G., et al. (2001) · Radiology · doi:10.1148/radiology.219.1.r01ap14101 · Cited by 300 · see citing works
β-Amyloid, Blood Vessels, and Brain Function
Smith, E. E., & Greenberg, S. M. (2009) · Stroke · doi:10.1161/strokeaha.108.536839 · Cited by 293 · see citing works
Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition
Maki, P. M., & Resnick, S. M. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00123-8 · Cited by 289 · see citing works
Babiloni, C., Binetti, G. G., Cassetta, E., Forno, G. D., Percio, C. D., Ferreri, F., Ferri, R., Frisoni, G. B., Hirata, K., Lanuzza, B., et al. (2005) · Clinical Neurophysiology · doi:10.1016/j.clinph.2005.09.019 · Cited by 282 · see citing works
“and hippocampus in MCI subjects, which were associated with a higher risk of progressive cognitive decline (Arnaiz et al., 2001; Huang et al., 2002; Johnson et al., 1998; Kitayama et al., 2001; Minoshima et al., 1994; Okamura et al., 2002; Rodriguez et al., 2000).”
Backgroundde la Torre, J. C. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00111-1 · Cited by 284 · see citing works
“[53] Johnson KA, Jones K, Holman BL, Becker J, Spiers PA, Satlin A,”
BackgroundInfluentialDisease-modifying therapies for Alzheimer disease
Cummings, J. L., Doody, R. S., & Clark, C. (2007) · Neurology · doi:10.1212/01.wnl.0000295996.54210.69 · Cited by 281 · see citing works
Govindpani, K., McNamara, L. G., Smith, N. R., Vinnakota, C., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050651 · Cited by 271 · see citing works
“It was shown that prior to clinical AD onset, hypoperfusion in the hippocampus, amygdala, posterior cingulate gyrus and left anterior thalamus precedes deficits in the temporoparietal cortex [75].”
BackgroundResultDissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment
Chetelat, G. (2003) · Brain · doi:10.1093/brain/awg196 · Cited by 264 · see citing works
“reported in two SPECT (single photon emission computed tomography) studies (Johnson et al., 1998; Kogure et al., 2000), as well as in non-demented subjects at risk of”
ResultStaging disease severity in pathologically confirmed cases of frontotemporal dementia
Broe, M., Hodges, J., Schofield, E., Shepherd, C., Kril, J., & Halliday, G. (2003) · Neurology · doi:10.1212/01.wnl.0000052685.09194.39 · Cited by 250 · see citing works
Luis, C. A., Loewenstein, D., Acevedo, A., Barker, W. W., & Duara, R. (2003) · Neurology · doi:10.1212/01.wnl.0000080366.90234.7f · Cited by 245 · see citing works
Vascular Basis of Alzheimer's Pathogenesis
de la Torre, J. C. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04817.x · Cited by 236 · see citing works
Valla, J. E., Berndt, J. D., & Gonzalez-Lima, F. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-13-04923.2001 · Cited by 237 · see citing works
“…been shown to exist very early in the course of AD (Minoshima et al., 1994, 1997; Reiman et al., 1996), and longitudinal studies show PCC dysfunction as a clinical predictor for later AD (Johnson et al., 1998; Kogure et al., 2000) that is correlated with severity of symptoms (Alsop et al., 2000).”
BackgroundCerebral blood flow and metabolic abnormalities in Alzheimer’s disease
Matsuda, H. (2001) · Annals of Nuclear Medicine · doi:10.1007/bf02988596 · Cited by 233 · see citing works
Neuroimaging in Alzheimer disease: an evidence-based review
Kantarci, K., & Jack, C. R. (2003) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(03)00025-x · Cited by 227 · see citing works
“PET [70] and SPECT [71] have also been shown to predict subsequent development of MCI and AD in clinically determined healthy elderly individuals and in individuals with questionable AD.”
BackgroundNestor, P. J., Fryer, T. D., Ikeda, M., & Hodges, J. R. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02999.x · Cited by 227 · see citing works
MRI and CSF studies in the early diagnosis of Alzheimer's disease
de Leon, M. J., DeSanti, S., Zinkowski, R. P., Mehta, P. D., Praticò, D., Segal, S., Clark, C. M., Kerkman, D. J., DeBernardis, J. F., Li, J., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01381.x · Cited by 221 · see citing works
Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment
Huang, C. C., Wahlund, L., Svensson, L., Winblad, B. G., & Julin, P. (2002) · BMC Neurology · doi:10.1186/1471-2377-2-9 · Cited by 219 · see citing works
“Johnson et al. demonstrated that SPECT was a promising method for the diagnosis of PMCI, in which the combination of the cingulate gyrus, hippocampal-amygdaloid complex and thalamus identified more than 80% of the subjects who would progress to AD after a 16.7 month follow-up [ 9 ].”
MethodInfluentialFleisher, A. S., Sherzai, A., Taylor, C., Langbaum, J. B. S., Chen, K., & Buxton, R. B. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.06.021 · Cited by 217 · see citing works
“The specific task used in our study has previously been reported to distinguish AD and MCI from normal controls (Dickerson et al., 2005; Sperling et al., 2003b), as well as identify cognitively normal individuals at increased risk for AD (Fleisher et al., 2008).”
InfluentialA critical discussion of the role of neuroimaging in mild cognitive impairment*
Wolf, H., Jelić, V., Gertz, H., Nordberg, A. K., Julin, P., & Wahlund, L. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.107.s179.10.x · Cited by 211 · see citing works
“5) who progressed to AD during the 2-year follow-up (94).”
BackgroundMethodAlzheimer disease: new concepts on its neurobiology and the clinical role imaging will play
Jack, C. R. (2012) · Radiology · doi:10.1148/radiol.12110433 · Cited by 211 · see citing works
Wu, X., Li, R., Fleisher, A., Reiman, E., Guan, X., Zhang, Y.-M., Chen, K.-W., & Yao, L. (2011) · Human Brain Mapping · doi:10.1002/hbm.21153 · Cited by 223 · see citing works
“Using PET and single-photon emission computerized tomography, reduced activity in PCC, parietal, temporal, and prefrontal cortices has been observed consistently [Johnson et al., 1998; Matsuda, 2001; Minoshima et al., 1997].”
MethodYuan, Y., Gu, Z.-X., & Wei, W.-S. (2008) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1357 · Cited by 205 · see citing works
“Eligible Studies Tables 2– 4 summarize the included studies, classified according to technique.(10-33) Our search strategy identified 326 artiTable 1: Diagnostic criteria of synonyms of MCI in eligible studies”
BackgroundMethodImaging the progression of Alzheimer pathology through the brain
Smith, A. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082107399 · Cited by 202 · see citing works
Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease
Bradley, K. M. (2002) · Brain · doi:10.1093/brain/awf185 · Cited by 202 · see citing works
“First, Johnson et al. (1998) described a small region of signi®cantly reduced perfusion in the caudal portion of the anterior cingulate.”
BackgroundInfluentialHippocampal hyperperfusion in Alzheimer's disease
Alsop, D. C., Casement, M. D., de BAZELAIRE, C., Fong, T. G., & Press, D. Z. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.06.006 · Cited by 200 · see citing works
“Metabolic imaging with Positron Emission Tomography (PET) (Friedland et al., 1983; Reiman et al., 1996; Small et al., 1995) and blood flow imaging with PET and Single Photon Emission Computed Tomography (SPECT) (Bonte et al., 2001; Johnson et al., 1998) have highlighted loss of activity in temporal, parietal, and fron…”
BackgroundInfluentialImaging and CSF Studies in the Preclinical Diagnosis of Alzheimer's Disease
de Leon, M. J., Mosconi, L., Blennow, K., DeSanti, S., Zinkowski, R. P., Mehta, P. D., Praticò, D., Tsui, W., Louis, L. A. S., Sobanska, L., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1379.012 · Cited by 198 · see citing works
Cerebral perfusion and oxygenation differences in Alzheimer's disease risk
Fleisher, A., Podraza, K. M., Bangen, K. J., Taylor, C. S., Sherzai, A. Z., Sidhar, K., Liu, T. T., Dale, A. M., & Buxton, R. B. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.012 · Cited by 182 · see citing works
Blood pressure and the risk for dementia—A double edged sword
Kennelly, S. P., Lawlor, B. A., & Kenny, R. A. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2008.11.001 · Cited by 173 · see citing works
“Brain hypoperfusion therefore may be a critical factor in the development of both VaD (Roman et al., 2002; Roman, 2004) and AD (Johnson et al., 1998).”
BackgroundChua, E. F., Schacter, D. L., Rand-Giovannetti, E., & Sperling, R. A. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2005.09.058 · Cited by 174 · see citing works
“Furthermore, AD patients have shown abnormalities on resting PET (Herholz et al., 2002; K. A. Johnson et al., 1998) and fMRI (Greicius et al., 2004; Lustig et al., 2003) studies in the lateral and medial parietal regions and in the posterior cingulate.”
BackgroundVascular oxidative stress in Alzheimer disease
Zhu, X., Smith, M. A., Honda, K., Aliev, G. M., Moreira, P. I., Nunomura, A., Casadesús, G., Harris, P. L. R., Siedlak, S. L., & Perry, G. L. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.039 · Cited by 175 · see citing works
“Neuroimaging studies supports the notion that in MCI patients who later converted to AD, the presence of temporoparietal (including hippocampal) hypoperfusion, hippocampal-parahippocampal hypoperfusion, and posteriorcingulate hypoperfusion distinguish this population group from other groups suggesting that hypoperfusi…”
BackgroundSystematic Review of the Diagnostic Accuracy of 99mTc-HMPAO-SPECT in Dementia
Dougall, N. J., Bruggink, S., & Ebmeier, K. P. (2004) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.12.6.554 · Cited by 210 · see citing works
Cognitive impairment in chronic obstructive pulmonary disease
Antonelli Incalzi, R., Marra, C., Giordano, A., Calcagni, M. L., Cappa, A., Basso, S., Pagliari, G., & Fuso, L. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1005-4 · Cited by 172 · see citing works
“Indeed, a perfusion deficit of select subcortical structures has been reported even in the earliest and preclinical stages of AD, whereas in H patients both blood gas derangement and smoke might be responsible for subcortical hypoperfusion [24, 29, 40].”
BackgroundAsllani, I., Habeck, C., Scarmeas, N., Borogovac, A., Brown, T. R., & Stern, Y. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600570 · Cited by 172 · see citing works
Chételat, G., Eustache, F., Viader, F., Sayette, V. D. L., Pèlerin, A., Mézenge, F., Hannequin, D., Dupuy, B., Baron, J., & Desgranges, B. (2005) · Neurocase · doi:10.1080/13554790490896938 · Cited by 164 · see citing works
“Previous studies report a significant hypometabolism in this area when comparing converters to nonconverters ( Drzezga et al , 2003 ; Chetelat et al , 2003a ; Huang et al , 2002 ), or to controls ( Minoshima et al , 1997; Johnson et al , 1998 ; 2001 ; Kogure et al , 2000 ).”
ResultAlzheimer's disease is a vasocognopathy: a new term to describe its nature
de la Torre, J. C. (2004) · Neurological Research · doi:10.1179/016164104225016254 · Cited by 167 · see citing works
Mild cognitive impairment: an epidemiological perspective
Ritchie, K. A. (2004) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2004.6.4/kritchie · Cited by 167 · see citing works
Synaptic Change in the Posterior Cingulate Gyrus in the Progression of Alzheimer's Disease
Scheff, S. W., PRICE, D. A., Ansari, M. A., Roberts, K. N., Schmitt, F. A., Ikonomović, M. D., & Mufson, E. J. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141518 · Cited by 163 · see citing works
“The PostC has been shown to have decreased perfusion in patients that convert to AD from MCI [35].”
Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease?
Celsis, P. (2000) · Annals of Medicine · doi:10.3109/07853890008995904 · Cited by 163 · see citing works
Kalback, W. M., Esh, C. L., Castaño, E. M., Rahman, A., Kokjohn, T. A., Luehrs, D. C., Sue, L. I., Cisneros, R., Gerber, F., Richardson, C., et al. (2004) · Neurological Research · doi:10.1179/016164104225017668 · Cited by 160 · see citing works
Borroni, B., Anchisi, D., Paghera, B., Vicini, B., Kerrouche, N., Garibotto, V., Terzi, A., Vignolo, L. A., Luca, M. D., Giubbini, R., et al. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.12.010 · Cited by 156 · see citing works
Matsuda, H., Kitayama, N., Ohnishi, T., Asada, T., Nakano, S., Sakamoto, S., Imabayashi, E., & Katoh, A. (2002) · PubMed · Cited by 158 · see citing works
Gefen, T. D., Peterson, M., Papastefan, S. T., Martersteck, A., Whitney, K. R., RADEMAKER, A. W., Bigio, E. H., Weıntraub, S., Rogalski, E. J., Mesulam, M. M., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2998-14.2015 · Cited by 157 · see citing works
“, 2002), hypoperfusion (Johnson et al., 1998; Huang et al., 2002), amyloid load, and neurofibrillary degeneration (Braak and Braak, 1991; Chu et al.”
BackgroundMatsuda, H., Mizumura, S., Nagao, T., Ota, T., Iizuka, T., Nemoto, K., Takemura, N., Arai, H., & Homma, A. (2007) · PubMed Central · Cited by 153 · see citing works
Exercise, cognition and Alzheimer's disease: More is not necessarily better
Eggermont, L. H. P., Swaab, D. F., Luiten, P. G. M., & Scherder, E. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.10.004 · Cited by 150 · see citing works
“More specifically, participants who developed AD late showed decreased perfusion in the hippocampal-amygdaloı̈d complex, the anterior and posterior cingulate and the anterior thalamus (Johnson et al., 1998; Matsuda, 2001).”
BackgroundReduced cerebral glucose metabolism in patients at risk for Alzheimer's disease
Hunt, A., Schönknecht, P., Henze, M., Seidl, U., Haberkorn, U., & Schröder, J. (2007) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2006.12.003 · Cited by 146 · see citing works
Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer’s disease
Dickerson, B. C., & Sperling, R. A. (2005) · Neurotherapeutics · doi:10.1602/neurorx.2.2.348 · Cited by 156 · see citing works
“Recent animal studies have suggested that antiamyloid strategies may result in acute changes in synaptic function and behavior, in addition to altering amyloid plaque formation.108,109 FMRI studies have demonstrated significant alterations in memory-related activation with the administration of pharmacologic agents kn…”
BackgroundChertkow, H. M., Massoud, F., Nasreddine, Z. S., Belleville, S., Joanette, Y., Bocti, C., Drolet, V., Kirk, J., Freedman, M., & Bergman, H. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.070797 · Cited by 143 · see citing works
Zhang, Y. S., Zhou, N., Knoll, B., Samra, S., Ward, M., Weıntraub, S., & Fawzi, A. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214685 · Cited by 144 · see citing works
Cholinergic modulation of the cortical microvascular bed
Hamel, É. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)45012-7 · Cited by 140 · see citing works
How do heart disease and stroke become risk factors for Alzheimer's disease?
de la Torre, J. C. (2006) · Neurological Research · doi:10.1179/016164106x130362 · Cited by 138 · see citing works
Modrego, P. J., Fayed, N., & Pina, M. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.667 · Cited by 135 · see citing works
Sun, S., Dong, L.-X., Cao, Y., Sun, H., & Yan, X. (2013) · Analytical Chemistry · doi:10.1021/ac401879y · Cited by 135 · see citing works
Pathophysiology of Neuronal Energy Crisis in Alzheimer’s Disease
de la Torre, J. C. (2008) · Neurodegenerative Diseases · doi:10.1159/000113681 · Cited by 134 · see citing works
Brain imaging in the study of Alzheimer's disease
Reiman, E. M., & Jagust, W. J. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.11.075 · Cited by 134 · see citing works
“shown to predict decline in MCI (Johnson et al., 1998) and are related to autopsy findings (Bonte et al.”
ResultResting-State Multi-Spectrum Functional Connectivity Networks for Identification of MCI Patients
Chong-yaw Wee, A., Yap, P., Denny, K., Browndyke, J. N., Potter, G. G., Welsh-Bohmer, K. A., Wang, L., & Shen, D. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037828 · Cited by 125 · see citing works
“Our findings of relative asymmetric pattern, i.e., more regions in the left hemisphere were selected in training stage, is in line with some previous studies using SPECT and PET data [53,54].”
ResultHippocampal Shape Analysis of Alzheimer Disease Based on Machine Learning Methods
Li, S., Shi, F., Pu, F., Li, X., Jiang, T., Xie, S., & Wang, Y. (2007) · American Journal of Neuroradiology · doi:10.3174/ajnr.a0620 · Cited by 125 · see citing works
“Moreover, several VBM studies, 16,46 sulcal-warping studies, 47,48 and single-photon emission CT and positron-emission tomography studies 49,50 supported a laterality trend of the atrophic process and left more than right hemispheric involvement in AD.”
BackgroundCritical threshold cerebral hypoperfusion causes Alzheimer's disease?
de la Torre, J. C. (1999) · Acta Neuropathologica · doi:10.1007/s004010051044 · Cited by 124 · see citing works
“Second, a recent longitudinal study using SPECT measurements of rCBF in elderly individuals with ‘questionable’ AD (i.e., subjects with memory trouble who did not meet NINDS/ADRDA criteria for ‘probable’ AD), revealed that only those subjects with significant cerebral hypoperfusion in the amygdaloid-hippocampal region…”
BackgroundResultInfluential
- Authors
- Johnson, K. A., Jones, K., Holman, B. L., Becker, J. A., Spiers, P. A., Satlin, A., & Albert, M. S.
- Affiliations
- Brigham and Women's Hospital (US)
- Venue
- Neurology
- Published
- 1998-06
- Volume
- 50
- Issue
- 6
- Pages
- 1563-1571
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W1964965688
- Cited by
- 471
- References
- 0
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 4 · 2023: 8 · 2022: 9 · 2021: 6 · 2020: 7 · 2019: 4 · 2018: 4 · 2017: 11 · 2016: 12 · 2015: 17 · 2014: 13 · 2013: 15 · 2012: 12
- FWCI
- 15.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ag009301-08)
- National Institute on Aging (R01-AG09301, P01AG004953)
- National Center for Research Resources (M01RR000088)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- Alzheimer's disease, single photon emission computed tomography, regional cerebral blood flow, singular value decomposition, posterior cingulate cortex, anterior thalamic nuclei, anterior cingulate cortex, apolipoprotein E, memory networks, cognitive decline
- MeSH terms
- Aged, Alzheimer Disease, Brain, Cerebrovascular Circulation, Female, Forecasting, Humans, Magnetic Resonance Imaging, Male, Neuropsychological Tests, Tomography, Emission-Computed, Single-Photon, Discriminant Analysis, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
